NephroGenex Reports Second Quarter 2015 Financial Results

Go back to NephroGenex Reports Second Quarter 2015 Financial Results

NephroGenex (NRX) Misses Q2 EPS by 16c

August 12, 2015 4:47 PM EDT

NephroGenex (NASDAQ: NRX) reported Q2 EPS of ($0.72), $0.16 worse than the analyst estimate of ($0.56).

For earnings history and earnings-related data on NephroGenex (NRX) click here.

... More